Megan Dell

Megan Dell practices at Willamette Valley Medical Center in Mcminnville, Oregon, part of Lifepoint Health.

Megan Dell's NPI, 1275672297, was assigned on February 6, 2007. Megan Dell graduated from University of Minnesota Medical School in 2005. Megan Dell holds Oregon license MD196425.

Megan Dell's primary practice is Willamette Valley Medical Center, at 2700 SE Stratus Ave., Mcminnville, OR 97128 in Yamhill County. The practice phone is (503) 472-6131.

Megan Dell's primary practice is Willamette Valley Medical Center in Mcminnville, Oregon, part of Lifepoint Health. Megan Dell is also affiliated with OHSU Hospital. The medical group on file is Emergency Medical Associates of McMinnville. Dmand AI also links Megan Dell to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Megan Dell practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Megan Dell's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Megan Dell's licenses on file in 2 states: Oregon and New Mexico.

CMS data shows 328 Medicare services from Megan Dell across 4 procedure codes in 2024, for 233 Medicare patients. Medicare paid $30,816 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 233 Medicare patients who saw Megan Dell in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 57% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Megan Dell's median patient age at 42, with 54% women.

In 2024, Megan Dell wrote 182 Medicare Part D claims for 129 patients. 98% of them were for generic drugs. CMS names the drug for 128 of them, across 7 drugs with 11 or more claims each, at $1,024 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Megan Dell for performance year 2024, reported as part of a group. Megan Dell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Megan Dell from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Purdue Pharma L.P. paid the most, $30.

Megan Dell graduated from University of Minnesota Medical School in 2005.